Sirolimus (LC–MS/MS) blood Biomarker Testing
It measures sirolimus in your blood to help guide dosing and safety monitoring, with convenient ordering through Vitals Vault using the Quest network.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.

A sirolimus LC–MS/MS test measures the amount of sirolimus (also called rapamycin) circulating in your blood. It is most often used as therapeutic drug monitoring (TDM) when you are taking sirolimus to prevent organ transplant rejection or to treat certain immune-related conditions.
Because sirolimus has a narrow “sweet spot,” the same dose can be too low for one person and too high for another. Your result helps your clinician decide whether your current dose and schedule are likely to be effective while staying as safe as possible.
How you time the blood draw matters. Many sirolimus results are interpreted as a trough level, meaning the sample is collected right before your next dose, so the number reflects your lowest level during the dosing interval.
Do I need a Sirolimus LC MS MS test?
You usually need sirolimus testing if you are currently prescribed sirolimus and your clinician wants to confirm that your blood level is in the intended target range for your situation. This is common after a transplant, after a dose change, when starting or stopping interacting medications, or when your kidney or liver function changes.
Testing can also be helpful if you have symptoms that could reflect an off-target level. If your level is too high, you might notice mouth sores, swelling, delayed wound healing, unusual bruising, higher infection risk, or lab changes such as rising cholesterol or triglycerides. If your level is too low, the concern is under-immunosuppression, which may not cause obvious symptoms early but can increase the risk of rejection in transplant settings.
You may be asked to retest if your dosing schedule is irregular, if you missed doses, or if the timing of the last blood draw was not clearly documented. A properly timed repeat test is often more useful than over-interpreting a single poorly timed result.
This test supports clinician-directed dosing decisions and safety monitoring; it does not diagnose a condition on its own.
Sirolimus is typically measured using a high-specificity LC–MS/MS method in a CLIA-certified laboratory; results must be interpreted with your dosing schedule and clinical context.
Lab testing
Order a Sirolimus LC–MS/MS test through Vitals Vault and schedule your draw.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
If you and your clinician want a current sirolimus level, Vitals Vault lets you order the lab test and complete your blood draw through a national lab network. This can be useful when you need a timely trough level after a dose change or when you are checking for interactions.
After your results post, you can use PocketMD to walk through what the number means in plain language, how timing affects interpretation, and which companion labs often matter for safety monitoring (such as kidney function, liver enzymes, lipids, and blood counts).
If your clinician adjusts your dose, you can use Vitals Vault to plan a follow-up level at the right time window, so you are trending the same type of measurement (for example, trough-to-trough) rather than comparing mismatched samples.
- Order online and complete your draw through a national lab network
- PocketMD helps you interpret timing, targets, and next-step questions
- Easy re-testing when your dose or medications change
Key benefits of Sirolimus LC MS MS testing
- Helps confirm whether your sirolimus exposure is likely to be therapeutic for your treatment plan.
- Supports safer dosing by identifying levels that may raise side-effect or infection risk.
- Clarifies whether a concerning result is due to dose timing versus a true change in drug level.
- Guides follow-up after starting, stopping, or changing medications that affect sirolimus metabolism.
- Helps your clinician respond to changes in kidney or liver function that can shift drug handling.
- Provides an objective checkpoint when symptoms (like mouth sores or swelling) suggest overexposure.
- Makes it easier to trend results over time when you repeat testing with consistent trough timing.
What is Sirolimus LC MS MS?
Sirolimus is an immunosuppressant medication that reduces immune activation by inhibiting mTOR (mechanistic target of rapamycin). It is used in transplant medicine and in selected immune-mediated conditions. Because the difference between “not enough” and “too much” can be small, clinicians often monitor blood levels to individualize dosing.
“LC–MS/MS” (liquid chromatography–tandem mass spectrometry) describes the measurement method. It is designed to be highly specific for sirolimus compared with older immunoassays, which can be more prone to cross-reactivity.
Most clinical monitoring uses a whole-blood sirolimus concentration, often interpreted as a trough level. Your clinician may set a target range based on your transplant type, time since transplant, other immunosuppressants you take, and your personal risk of rejection or adverse effects.
Why timing (trough vs random) matters
Sirolimus levels change throughout the day after you take a dose. A trough sample is drawn right before your next scheduled dose and is the most common way to compare results over time. A “random” level can still be informative, but it is harder to interpret unless the exact time since your last dose is documented.
What the test does not tell you
A sirolimus level does not directly measure immune function, rejection, or infection. It is one piece of monitoring that is usually paired with clinical assessment and other labs, such as kidney function, liver enzymes, lipids, and a complete blood count.
What do my Sirolimus LC MS MS results mean?
Low sirolimus level
A low result often means your body is seeing less sirolimus than intended, which can happen if your dose is too small, doses are missed, absorption is reduced, or the blood draw was not a true trough. In transplant care, a persistently low trough can increase the risk of under-immunosuppression and rejection, especially if other immunosuppressants are also low or have been reduced. Do not change your dose on your own; the next step is usually confirming dose timing and reviewing interacting medications before repeating a properly timed level.
In-range (target) sirolimus level
An in-range result suggests your current dosing schedule is producing the exposure your clinician is aiming for. “Optimal” is individualized, so your target may differ from someone else’s depending on your diagnosis, time since transplant, and combination therapy. Even with a target level, you still need routine safety monitoring because side effects can occur at therapeutic concentrations, particularly when other risk factors are present.
High sirolimus level
A high result means your sirolimus exposure may be above the intended target, which can raise the likelihood of adverse effects such as mouth ulcers, swelling, delayed wound healing, higher lipid levels, low blood counts, or increased infection risk. High levels can also occur when a sample is drawn too soon after a dose rather than at trough. Your clinician will typically review timing, recent dose changes, and interacting drugs, and may adjust your dose and recheck the level after you have been on the new regimen long enough to reach a steady pattern.
Factors that influence sirolimus levels
The biggest driver is timing relative to your last dose, so write down when you took sirolimus and when your blood was drawn. Drug interactions are common because sirolimus is metabolized through CYP3A and transported by P-glycoprotein; certain antibiotics, antifungals, seizure medications, and some cardiovascular drugs can raise or lower levels. Liver function changes can increase exposure, and gastrointestinal issues can reduce absorption. Consistency also matters: switching formulations, changing meal patterns around dosing, or taking the medication inconsistently can make levels harder to interpret.
What’s included
- Sirolimus, Lc/Ms/Ms
Frequently Asked Questions
Is sirolimus the same as rapamycin?
Yes. Sirolimus is the generic drug name, and rapamycin is another name commonly used for the same medication. The lab test measures sirolimus in your blood.
Do I need to fast for a sirolimus LC–MS/MS blood test?
Fasting is not usually required for the sirolimus level itself. What matters most is consistent timing relative to your dose. If your clinician also orders lipids or other tests at the same visit, they may ask you to fast for those.
When should my blood be drawn for a sirolimus trough level?
A trough level is typically drawn immediately before your next scheduled dose. Take your medication after the blood draw unless your clinician gives different instructions. If you cannot do a true trough, document the exact time of your last dose and the time of the draw.
What is a normal sirolimus level?
There is not one universal “normal” because sirolimus is a medication with individualized therapeutic targets. Your clinician sets a goal range based on why you take it, your other immunosuppressants, and your risk profile. Use the target range provided by your transplant or treating team rather than comparing to someone else’s number.
What medications can interact with sirolimus and change my level?
Many drugs can raise or lower sirolimus by affecting CYP3A metabolism or P-glycoprotein transport. Common categories include certain antifungals, macrolide antibiotics, some seizure medications, and some cardiovascular medications. Always review new prescriptions and over-the-counter products with your clinician or pharmacist before assuming your level change is due to dosing alone.
How soon after a dose change should I recheck a sirolimus level?
Your clinician will choose timing based on your clinical situation, but rechecking is often done after you have been on the new dose long enough for levels to stabilize and for a properly timed trough to be meaningful. If there is concern for toxicity or a major interaction, they may recheck sooner.
Why might my sirolimus level be high if I did not change my dose?
A level can rise due to a non-trough blood draw (sample taken soon after dosing), a new interacting medication, changes in liver function, dehydration/illness affecting absorption and metabolism, or inconsistent dosing. Confirming timing and reviewing recent medication changes are usually the first steps.